Trial Profile
A Phase II/III Randomized, Multicenter Trial Comparing Sirolimus Plus Prednisone and Sirolimus/Calcineurin Inhibitor Plus Prednisone for the Treatment of Chronic Graft-Versus-Host Disease.
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 07 Dec 2013
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus (Primary) ; Prednisone
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 05 Oct 2013 New trial record